A Multilevel Framework for Evaluating the Impact of Monoclonal Antibodies Against Respiratory Syncytial Virus in Daycare and Households
- 1Yale School of Public Health
Abstract
Monoclonal antibodies (mAbs) reduce the risk of severe disease caused by respiratory syncytial virus (RSV) among immunized infants. The potential of these products to indirectly protect unimmunized contacts remains incompletely understood. This uncertainty is, in part, due to our limited understanding of how mAbs may influence population-level RSV transmission. Here, we develop a multiscale simulation framework that integrates RSV transmission dynamics across households and daycare centers to explore the characteristics of the population that could influence the strength of indirect effects of infant mAb immunization. The framework incorporates individual-level heterogeneity in age and time-varying infectiousness, as well as demographic variation in household composition and contact patterns, to capture realistic transmission pathways across close-contact networks. Using a virtual population informed by U.S. household characteristics, we show that infant immunization would only be expected to provide modest indirect protection to toddlers, and the magnitude of these effects depends on contact structure and intervention coverage. Our findings demonstrate the importance of integrating fine-scale transmission networks into evaluations of RSV prevention strategies and provide a generalizable framework for assessing population-level impacts of interventions against respiratory pathogens.
Related
- Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va
- Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
- Real-time wearable detection of respiratory infections in pediatric transplant households
- Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers
- Anti-Nectin4 monoclonal antibodies attenuate airway inflammation and epithelial barrier dysfunction in asthma
BibTeX
@misc{li2026multilevel,
title = {{A Multilevel Framework for Evaluating the Impact of Monoclonal Antibodies Against Respiratory Syncytial Virus in Daycare and Households}},
author = {K. Li and V. E. Pitzer and D. Weinberger},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.03.26367194},
url = {https://www.medrxiv.org/content/10.64898/2026.11.03.26367194v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - A Multilevel Framework for Evaluating the Impact of Monoclonal Antibodies Against Respiratory Syncytial Virus in Daycare and Households
AU - K. Li
AU - V. E. Pitzer
AU - D. Weinberger
PY - 2026
DA - 2026/11/03
PB - medRxiv
DO - 10.64898/2026.11.03.26367194
UR - https://www.medrxiv.org/content/10.64898/2026.11.03.26367194v1
AB - Monoclonal antibodies (mAbs) reduce the risk of severe disease caused by respiratory syncytial virus (RSV) among immunized infants. The potential of these products to indirectly protect unimmunized contacts remains incompletely understood. This uncertainty is, in part, due to our limited understanding of how mAbs may influence population-level RSV transmission. Here, we develop a multiscale simulation framework that integrates RSV transmission dynamics across households and daycare centers to explore the characteristics of the population that could influence the strength of indirect effects of infant mAb immunization. The framework incorporates individual-level heterogeneity in age and time-varying infectiousness, as well as demographic variation in household composition and contact patterns, to capture realistic transmission pathways across close-contact networks. Using a virtual population informed by U.S. household characteristics, we show that infant immunization would only be expected to provide modest indirect protection to toddlers, and the magnitude of these effects depends on contact structure and intervention coverage. Our findings demonstrate the importance of integrating fine-scale transmission networks into evaluations of RSV prevention strategies and provide a generalizable framework for assessing population-level impacts of interventions against respiratory pathogens.
ER -